410 results on '"Giorgini, Flaviano"'
Search Results
2. Publisher Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington’s disease
3. Author Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
4. Publisher Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
5. Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
6. Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
7. Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics
8. Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases
9. Visualization of Mutant Aggregates from Clock Neurons by Agarose Gel Electrophoresis (AGERA) in Drosophila melanogaster
10. Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models
11. Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
12. The origin, evolution, and molecular diversity of the chemokine system
13. Mutant huntingtin impairs immune cell migration in Huntington disease
14. Author Reply to Peer Reviews of The origin, evolution and molecular diversity of the chemokine system
15. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders
16. The Parkinson’s Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration
17. The origin, evolution and molecular diversity of the chemokine system
18. Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
19. A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
20. DJ-1 Molecular Chaperone Activity Depresses Tau Aggregation Propensity through Interaction with Monomers
21. The kynurenine pathway and neurodegenerative disease
22. Tubulin Isotypes and Posttranslational Modifications in Vascular Dementia and Alzheimer’s Disease
23. α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner
24. Assessing and Modulating Kynurenine Pathway Dynamics in Huntington’s Disease: Focus on Kynurenine 3-Monooxygenase
25. Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase
26. Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington’s disease models
27. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane
28. Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN
29. A flexible polyglutamine hinge opens new doors for understanding huntingtin function
30. Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity
31. Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
32. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane
33. Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity
34. Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
35. Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
36. A Network of Protein Interactions Determines Polyglutamine Toxicity
37. Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour
38. Structural basis of kynurenine 3-monooxygenase inhibition
39. Contributors
40. Modeling Huntington Disease in Yeast and Invertebrates
41. The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease
42. Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells
43. Tubulin and Tubulin Posttranslational Modifications in Alzheimer’s Disease and Vascular Dementia
44. Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
45. Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment
46. The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity
47. Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntingtonʼs disease
48. DJ-1 modulates aggregation and pathogenesis in models of Huntingtonʼs disease
49. Erratum to: Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
50. Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.